Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,053 INR | -0.68% | -2.41% | +23.34% |
04-29 | Glenmark Pharmaceuticals Gets US FDA's Final Approval for Generic Pain Relief Medicines | MT |
04-25 | Glenmark Lifesciences' Net Profit Slides in Fiscal Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+23.34% | 3.56B | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- GLENMARK Stock
- News Glenmark Pharmaceuticals Limited
- Glenmark Pharmaceuticals : , Alembic, Ipca Invest in ABCD Technologies; Stakes of Dr. Reddy's, Others Reduced